Search

Displaying results 5331 - 5340 of 7604 in total
  1. Drug

    Oxandrolone

    go.drugbank.com/drugs/DB00621
    ApprovedInvestigational

    A synthetic hormone with anabolic and androgenic properties.

  2. Drug

    Veliflapon

    go.drugbank.com/drugs/DB16346
    Investigational

    Veliflapon is under investigation in clinical trial NCT00353067 (Veliflapon (Dg-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina).

    Categories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal
  3. Drug

    Methylselenocysteine

    go.drugbank.com/drugs/DB12697
    Investigational

    Methylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.

  4. Drug

    Inactivated SARS-Cov-2 Vaccine

    go.drugbank.com/drugs/DB15862
    Investigational

    Developed by Sinopharm's Wuhan Institute of Biological Products co., this vaccine consists of the WIV04 strain of SARS-CoV-2.

  5. Drug

    Poa annua pollen

    go.drugbank.com/drugs/DB10353
    Approved

    Poa annua pollen is the pollen of the Poa annua plant. Poa annua pollen is mainly used in allergenic testing.

    Categories: Non-Standardized Pollen Allergenic Extract
  6. Drug

    Distichlis spicata pollen

    go.drugbank.com/drugs/DB10494
    Approved

    Distichlis spicata pollen is the pollen of the Distichlis spicata plant. Distichlis spicata pollen is mainly used in allergenic testing.

    Categories: Non-Standardized Pollen Allergenic Extract
  7. Drug

    Urochloa mutica pollen

    go.drugbank.com/drugs/DB10716
    Approved

    Urochloa mutica pollen is the pollen of the Urochloa mutica plant. Urochloa mutica pollen is mainly used in allergenic testing.

    Categories: Non-Standardized Pollen Allergenic Extract
  8. Drug

    AAV9/MFSD8

    go.drugbank.com/drugs/DB18616
    Experimental

    AAV9/MFSD8 is a gene therapy developed by Neurogene Inc.

  9. Drug

    Devafidugene civaparvovec

    go.drugbank.com/drugs/DB16790
    Investigational

    Developed by Sangamo Therapeutics, Inc., devafidugene civaparvovec is being investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46716]

  10. Drug

    NGN-401

    go.drugbank.com/drugs/DB18594
    Investigational

    Developed by Neurogene Inc., it is being investigated for the treatment of Rett syndrome.